Donald E. Bobo Jr., CVP, Strategy/Corp Development at Edwards Lifesciences Corp (EW), sold 21,530 shares at $85.81 ($1.8M) on 2024-02-13, disclosed to the SEC on 2024-02-13.
Scheduled sale ($1.8M) by CVP, Strategy/Corp Development under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.81 | 10,530 | $904K | 48.9% |
| 2 | $85.81 | 10,530 | $904K | 48.9% |
| 3 | $86.35 | 470 | $41K | 2.2% |
| Total | $85.82 avg | 21,530 | $1.8M | 100% |
| Filing → |
| EW | SELL | 2026-04-02 | $1.8M | — | Filing → |
| EW | SELL | 2026-03-02 | $1.9M | — | Filing → |
| EW | SELL | 2026-02-26 | $2.0M | — | Filing → |